|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
| Trial Status | Open |
| Dates | Date of activation: 07/01/2008 |
| Data management at EORTC | Full |
| Phase | 2-3 |
| Randomized trial | Yes |
| Type | Hemato-malign |
| Targeted Sample size | EORTC Groups: 50 - All Groups: 445 |
| Number of steps | 2 |
| Drug | Prednisone Dexamethasone (DXM) Vincristine (VCR) Cytosine arabinoside (ARA-C) Daunorubicin (DNR) Asparaginase Pegaspargase Methotrexate (MTX) Cyclophosphamide (CPM) 6-mercaptopurine (6-MP) 6-thioguanine (6-TG) Etoposide (VP 16) Mitoxantrone |
| Study Staff | Alice Ferster (Study Coordinator) - Hopital Universitaire Des Enfants Reine Fabiola, Brussels Stefan Suciu (Statistician) - EORTC, Brussels Lies Meirlaen (Data Manager) - EORTC, Brussels Steven Mortier (Project Manager) - EORTC, Brussels, steven.mortier( at )eortc.be, +32 2 7741607 |
| Type of cancer | Acute Lymphocytic Leukemia |
| Participating Groups | Operating Center for Research and Statistics(Coordinating Group) EORTC Children's Leukemia Group French Acute Lymphoblatic Leukemia |
| Currently authorized centers | Universiteit Gent (Gent, Belgium) - Inst. 104 Clinique De L'Esperance (Saint-Nicolas (montegnee), Belgium) - Inst. 110 Cliniques Universitaires St. Luc (Brussels, Belgium) - Inst. 121 Universitair Ziekenhuis Brussel (Brussels, Belgium) - Inst. 128 Centre Hospitalier Regional De La Citadelle (Liege, Belgium) - Inst. 145 U.Z. Gasthuisberg (Leuven, Belgium) - Inst. 147 Hopital Universitaire Des Enfants Reine Fabiola (Brussels, Belgium) - Inst. 159 Chr De Besancon - Hopital Saint-Jacques (Besancon, France) - Inst. 204 Chr De Grenoble - La Tronche (Grenoble, France) - Inst. 215 CHU Lyon - Institut d'Hematologie et d'Oncologie Pediatrique (Lyon, France) - Inst. 239 Hopital Universitaire Hautepierre (Strasbourg, France) - Inst. 240 Hopital Arnaud De Villeneuve (Montpellier, France) - Inst. 244 Chru De Nancy - Hopitaux De Brabois (Vandoeuvre-Les-Nancy, France) - Inst. 251 CHU Amiens - Hopital Nord (Amiens, France) - Inst. 253 C.H.R. De Lille (Lille, France) - Inst. 254 C.H.U. De Brest (Brest, France) - Inst. 263 Hopital Americain (Reims, France) - Inst. 265 Hopital Charles Nicolle (Rouen, France) - Inst. 266 C.H.U. - Hotel-Dieu (Clermont-Ferrand, France) - Inst. 268 C.H.R.U. De Caen (Caen, France) - Inst. 273 Assistance Publique - Hôpitaux de Marseille - C.H.U. De La Timone (Marseille, France) - Inst. 287 Hopital Jean Bernard (Poitiers, France) - Inst. 296 Chu De Rennes - Hopital Sud (Rennes, France) - Inst. 298 Hopital Robert Debre AP-HP (Paris, France) - Inst. 408 Chu De Bordeaux - Hopital Pellegrin (Bordeaux, France) - Inst. 2211 Hopital Du Bocage (Dijon, France) - Inst. 2217 Hopital De L'Archet (Nice, France) - Inst. 2292 Hopital Armand Trousseau AP-HP (Paris, France) - Inst. 2307 Hopital Des Enfants (Toulouse, France) - Inst. 2316 Hopital Mere-Enfant CHU (Nantes, France) - Inst. 9041 CHU de Tours - Centre de Pédiatrie Gatien de Clocheville (Tours, France) - Inst. 9000 Institut de Cancerologie de la Loire (Saint-Priest-en-Jarez (St-Etienne), France) - Inst. 9019 Instituto Portugues De Oncologia - Centro Do Porto (Porto, Portugal) - Inst. 804 |
| Protocol summary | Link provided by NCI PDQ |
| Protocol documents in PDF (requires password) | 58051.pdf |